# PRIMA-HF: Predicting Myocardial Recovery in Heart Failure Using Cardiac Imaging HAI-HF: High Dosing vs. Standard Dosing Adenosine During Myocardial Perfusion in Heart Failure

> **NCT07243119** · PHASE4 · ENROLLING_BY_INVITATION · sponsor: **Gødstrup Hospital** · enrollment: 180 (estimated)

## Conditions studied

- Heart Failure and Reduced Ejection Fraction
- Heart Failure

## Interventions

- **DIAGNOSTIC_TEST:** HAI-HF: Adenosine Stress [¹⁵O]H₂O PET Imaging
- **DRUG:** Two different doses of adenosine

## Key facts

- **NCT ID:** NCT07243119
- **Lead sponsor:** Gødstrup Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-12-08
- **Primary completion:** 2029-04-30
- **Final completion:** 2029-04-30
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2025-12-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07243119

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07243119, "PRIMA-HF: Predicting Myocardial Recovery in Heart Failure Using Cardiac Imaging HAI-HF: High Dosing vs. Standard Dosing Adenosine During Myocardial Perfusion in Heart Failure". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07243119. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*